Search
Galectin Therapeutics Inc
GALTAdd to Watchlist
3.660USD
+0.210+6.09%
Close 07-23 16:00（ET）Quotes delayed by 15 min
241.04MMarket Cap
LossP/E TTM
GALT Financials
See Galectin Therapeutics Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.
Galectin Therapeutics Inc Earnings Date
Latest Release
May 15, 2026
EPS / Forecast
-0.08/-0.06
Revenue / Forecast
--/0.00
Period
FY2025 Earnings
Revenue(YoY)
--
--
EPS(YoY)
-0.48
36.01%
Analyst Rating
BUY
2026/07/23
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FAQs
What are the current assets of Galectin Therapeutics Inc?
According to Galectin Therapeutics Inc's FY2025 earnings report, its current assets were 19.44M, with a year-on-year change of 12.66.
What are the total assets of Galectin Therapeutics Inc?
According to Galectin Therapeutics Inc's FY2025 earnings report, its total assets of Galectin Therapeutics Inc were 19.53M, with a year-on-year change of 11.64.
What are the total liabilities of Galectin Therapeutics Inc?
According to Galectin Therapeutics Inc's FY2025 earnings report, its total liabilities of Galectin Therapeutics Inc were 145.73M, with a year-on-year change of 20.87.
What is the total equity of Galectin Therapeutics Inc?
According to Galectin Therapeutics Inc's FY2025 earnings report, its total equity of Galectin Therapeutics Inc was -126.19M, with a year-on-year change of -22.44.
What is the net operating income of Galectin Therapeutics Inc?
According to Galectin Therapeutics Inc's FY2025 earnings report, its net operating income of Galectin Therapeutics Inc was -20.09M, with a year-on-year change of 52.67.
What is the net financing of Galectin Therapeutics Inc?
According to Galectin Therapeutics Inc's FY2025 earnings report, its net financing of Galectin Therapeutics Inc was 26.48M, with a year-on-year change of -15.22.
What is the Earnings Per Share (EPS) of Galectin Therapeutics Inc?
According to Galectin Therapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -0.48, with a year-on-year change of 36.01.
What is the net income of Galectin Therapeutics Inc?
According to Galectin Therapeutics Inc's FY2025 earnings report, its net income was -30.97M, with a year-on-year change of 34.38.
What is the debt-to-asset ratio of Galectin Therapeutics Inc?
According to Galectin Therapeutics Inc's FY2025 earnings report, its debt-to-asset ratio was 684.70, with a year-on-year change of 12.77.
What is the Return on Assets (ROA) of Galectin Therapeutics Inc?
According to Galectin Therapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was -166.56, with a year-on-year change of 19.11.
What is the operating profit of Galectin Therapeutics Inc?
According to Galectin Therapeutics Inc's FY2025 earnings report, its operating profit was -20.09M, with a year-on-year change of 52.67.